beta
IMDZ
Immune Design Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Immune Design Corp is a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease.
Market Cap: 180 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.immunedesign.com
Shares Outstanding: 48.1 Million
Float: 47.6 Million
Dividend: 0.0 (0.0%)
Beta: 2.101459
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1079 trading days
From: 2014-12-22 To: 2019-04-01
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|